Abstract:Infectious diseases remain one of the leading causes of morbidity and mortality worldwide. The WHO and CDC have expressed serious concern regarding the continued increase in the development of multidrug resistance among bacteria. Therefore, the antibiotic resistance crisis is one of the most pressing issues in global public health. Associated with the rise in antibiotic resistance is the lack of new antimicrobials. This has triggered initiatives worldwide to develop novel and more effective antimicrobial compounds as well as to develop novel delivery and targeting strategies. Bacteria have developed many ways by which they become resistant to antimicrobials. Among those are enzyme inactivation, decreased cell permeability, target protection, target overproduction, altered target site/enzyme, increased efflux due to over-expression of efflux pumps, among others. Other more complex phenotypes, such as biofilm formation and quorum sensing do not appear as a result of the exposure of bacteria to antibiotics although, it is known that biofilm formation can be induced by antibiotics. These phenotypes are related to tolerance to antibiotics in bacteria. Different strategies, such as the use of nanostructured materials, are being developed to overcome these and other types of resistance. Nanostructured materials can be used to convey antimicrobials, to assist in the delivery of novel drugs or ultimately, possess antimicrobial activity by themselves. Additionally, nanoparticles (e.g., metallic, organic, carbon nanotubes, etc.) may circumvent drug resistance mechanisms in bacteria and, associated with their antimicrobial potential, inhibit biofilm formation or other important processes. Other strategies, including the combined use of plant-based antimicrobials and nanoparticles to overcome toxicity issues, are also being investigated. Coupling nanoparticles and natural-based antimicrobials (or other repurposed compounds) to inhibit the activity of bacterial efflux pumps; formation of biofilms; interference of quorum sensing; and possibly plasmid curing, are just some of the strategies to combat multidrug resistant bacteria. However, the use of nanoparticles still presents a challenge to therapy and much more research is needed in order to overcome this. In this review, we will summarize the current research on nanoparticles and other nanomaterials and how these are or can be applied in the future to fight multidrug resistant bacteria.

Nano Revolution: Harnessing Nanoparticles to Combat Antibiotic-resistant Bacterial Infections

Harnessing Nanoparticles to Overcome Antimicrobial Resistance: Promises and Challenges

Nanomedicines as a cutting-edge solution to combat antimicrobial resistance

Nanotechnology as a Novel Approach in Combating Microbes Providing an Alternative to Antibiotics

Nanotechnology: a contemporary therapeutic approach in combating infections from multidrug-resistant bacteria

Advancements in Nanoparticle-Based Strategies for Enhanced Antibacterial Interventions

Nanoantibiotics: Future Nanotechnologies to Combat Antibiotic Resistance.

Progress and prospects of nanomaterials against resistant bacteria

Nano-Strategies to Fight Multidrug Resistant Bacteria-"A Battle of the Titans"

Antibiotic-Free Antibacterial Strategies Enabled by Nanomaterials: Progress and Perspectives.

Exploring bio-nanomaterials as antibiotic allies to combat antimicrobial resistance

Antimicrobial Applications of Nanoparticles

Revolutionizing Antibacterial Strategies: Lipid Nanoparticles as Game-Changers in Combatting Multi-Drug-Resistant Infections

Nanotechnology-A Light of Hope for Combating Antibiotic Resistance

Application of nano-antibiotics in the diagnosis and treatment of infectious diseases

Emerging Nanobiomaterials Against Bacterial Infections in Postantibiotic Era

Treatment of antibiotic-resistant bacteria by nanoparticles: Current approaches and prospects

Nanomedicine Fight against Antibacterial Resistance: An Overview of the Recent Pharmaceutical Innovations

Nanotechnology in the Diagnosis and Treatment of Antibiotic-Resistant Infections

Nanobiotechnological Approaches Against Multidrug Resistant Bacterial Pathogens: An Update.

Nanomaterial-based strategies in antimicrobial applications: Progress and perspectives